Clinical data are compelling: In Phase 2 trials, retatrutide achieved up to 24.2% body weight reduction at 48 weeks with the highest dose, alongside HbA1c reductions of up to 2.02%results that surpass those of dual agonists and many existing therapies
Mia Taylor, Finnair sparks controversy by weighing its passengers, BBC, February 21, 2014, [69]
If you experience reflux or nocturnal gastrointestinal discomfort, you might find it helpful to avoid eating within 23 hours of bedtime
The Food and Drug Administration has sought to tighten limits after shortages of the branded drugs that allowed compounding to flourish ended
As the number of approved GLP-1 medications grows, clinicians will increasingly be able to choose from a menu of options, some of which may be especially appropriate for individual patients
C., Christensen, M